Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Harvey’s British Eatery is a 35 to 40 cover eatery focused on re-establishing the heritage of British cooking. Harvey’s recipes draw on the best in the British Isles, using seasonal ingredients. The investment will be used to take their eatery to a permanent site in London.
(SEIS partial)
days to go:
Expired
investment:
£193,550
The Studio enable members to achieve results through sustainable, structured training. The Studio offer a whole range of sessions such as group classes, one-to-one personal training, spinning and yoga.
days to go:
Expired
investment:
£30,564
Erpingham House is the UK’s largest vegan restaurant whose aim is to make plant-based dining into the mainstream and provide delicious, healthy food and drinks to people. The company has earned nationwide recognition and, it has been listed in The Times top 20 vegetarian restaurants. It has also been featured in The Guardian and on channel 4’s “what Britain bought.” EH has served over 12,000 customers in its first year and, it has risen to over 20,000 followers on Instagram. The funds will be used to expand the brand & open a second site in Brighton.
days to go:
Expired
investment:
£192,280
Champion & Reeves is a confectionery brand that manufactures and distributes 100% natural, high quality confectionary. They currently have orders placed from locations such as Buckingham Palace and Windsor Castle.
days to go:
Expired
investment:
£156,540
Frankie goes to Bollywood are setting out to change the perception of Indian food. They have opened a restaurant with the concept of Indian flavours meet British fast food favourites. Following thier success of the restaurant they are now looking for funding to fit out a new premise in East London and working capital.
(SEIS Pending)
days to go:
Expired
investment:
£51,420
The UK's first authentic iced milk tea / brewed chai, combining the speciality of flavoured teas with the status of milk tea. Tuk Tuk Chai launched in 2017 with products available at 110 Sainsbury’s stores and Harvey Nichols. The firm has won multiple awards including 'Most Innovative Product' at the Lunch! 2017 trade show and were finalists for 2017 Virgin Foodpreneur. In 2018, Peter Jones of Dragon's Den made an investment offer towards the company.
days to go:
Expired
investment:
£275,920
Creating Scottish cocktails that are high quality and ready-to-drink. The Venom Project's drinks consist of 5 flavours available in cans that contain 8% alcohol and are currently sold in off-licenses in Scotland, as well as over 300 retailers. In the first 7 months of trading, the company has been listed by over 250 stockists and sold more than 150k units. This has resulted in sales of £500k with the team growing from 3 to 10 members to handle demand.
More than 250 stores have requested re-orders on a monthly basis and The Venom Project has predicted that 250k units per month will be reached in the near future. Funds will allow the company to escalate their manufacturing process to meet consumer demand, as well as acquire more stockists to attract new customers to the brand. A new manufacturing process will also allow the business to print their cans, which will aid in reducing production costs.
days to go:
Expired
investment:
£62,170
